The independent source for health policy research, polling, and news.
1,181-1,200 of 4,007 results
Recent leaps in medical research have lent urgency to the quest to develop a vaccine against Epstein-Barr, a ubiquitous virus that has been linked to a range of illnesses, from mononucleosis to multiple sclerosis and several cancers.
Centene is trying to settle accusations of Medicaid pharmaceutical overcharging in Georgia, and the St. Louis-based company has been giving thousands of dollars to the campaigns of the state attorney general and the governor.
The cheaper over-the-counter aids are for adults with mild to moderate hearing loss — a market of tens of millions of people, many of whom have until now been priced out because prescription devices can cost thousands of dollars.
California put up $100 million to produce its own insulin. How did this plan come to be, and what might stand in the state’s way?
Independent medical practices keep closing as doctors join behemoth hospital groups or leave the field. Research suggests that’s bad news for patients. Studies repeatedly conclude that consolidation in the health care industry is driving up costs while showing no clear evidence of improved care.
The human body mass index — a simple mathematical equation — is tied to a measure of obesity invented almost 200 years ago. On the downside, it can stand between patients and treatment for weight issues. It particularly mismeasures Black women and Asians.
Hospitals have specialists ready to offer consult and care for concerns from cancer to childbirth but often no one with expertise in addiction medicine. Patients with a history of substance use — who are discharged without care — are at risk for overdose.
Hundreds of medical centers along the Atlantic and Gulf coasts face serious risks from even relatively weak storms as climate change accelerates sea-level rise — not to mention big ones like Category 4 Hurricane Ian.
Congress won’t be back in Washington until after Election Day, but lawmakers have left themselves a long list of items to finish up in November and December, including unfinished health care policies. Sandhya Raman of CQ Roll Call; Jessie Hellmann, also of CQ Roll Call; and Mary Agnes Carey of KHN join KHN’s Julie Rovner to discuss these topics and more. Also this week, Rovner interviews KHN’s Sam Whitehead, who reported and wrote the latest KHN-NPR “Bill of the Month” episode about a family who tried to use urgent care to save money, but ended up with a big emergency room bill anyway.
New policies to prevent unpaid medical bills from harming people’s credit scores are on the way. But the concessions made by top credit reporting companies may fall short for those with the largest debt — especially Black Americans in the South.
Penny Wingard, 58, of Charlotte, North Carolina, worries she won’t ever get out from under her medical debt despite new policies that are supposed to prevent medical debt from harming people’s credit scores.
Private Medicare Advantage health plans are increasingly ending coverage for skilled nursing or rehab services before medical providers think patients are healthy enough to go home, doctors and patient advocates say.
An industry has grown up around sleep apnea, stirring concerns about overdiagnosis and overtreatment.
Since pharmaceutical companies started funding their FDA drug applications 30 years ago, the agency’s reviews have gone much faster — perhaps too fast.
Congress has once again decided not to decide how to fund the federal government in time for the start of the fiscal year, racing toward a midnight Sept. 30 deadline to pass a stopgap bill that would keep the lights on for two more months. However, it does appear the FDA’s program that gets drugmakers to help fund some of the agency’s review staff will be renewed in time to stop pink slips from being sent. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Victoria Knight of Axios join KHN’s Julie Rovner to discuss these topics and more. Also this week, Rovner interviews filmmaker Cynthia Lowen, whose new documentary, “Battleground,” explores how anti-abortion forces played the long game to overturn Roe v. Wade.
Some hospitals notch big profits while patients are pushed into debt by skyrocketing medical prices and high deductibles, a KHN analysis finds.
When Indigenous people started moving to cities in large numbers after World War II, many found hardship and discrimination there … but not the health care they were entitled to. Episode 12, the season finale, explores the efforts of urban Indian health providers to close those gaps by providing affordable, culturally competent care.
Four Seasons Health Care collapsed after years of private equity investors rolling in one after another to buy its business, sell its real estate, and at times wrest multimillion-dollar profits from it through complex debt schemes. The deal-making failed to account for the true cost of senior care.
A cannabis product called delta-8 was made legal when the 2018 Farm Bill legalized hemp. But unlike its cousin CBD, delta-8 has psychoactive properties. And the FDA warns it has “serious health risks.” The agency has received more than 100 reports of bad reactions among people who consumed it.
President Joe Biden, in an interview with CBS’ “60 Minutes,” declared the covid-19 pandemic “over,” stoking confusion for members of his administration trying to persuade Congress to provide more funding to fight the virus and the public to get the latest boosters. Meanwhile, concerns about a return of medical inflation is helping boost insurance premiums even as private companies race to get their piece of the health pie. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Lauren Weber of KHN join KHN’s Julie Rovner to discuss these issues and more. Also, for extra credit, the panelists suggest their favorite health policy stories they think you should read, too.
© 2026 KFF